Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03841032 · ClinicalTrials.gov registry record · NA
4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness
A NA study of Rosacea, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT03841032 is a NA study of Rosacea that has completed, run by Bayer. The registered enrollment target is 35 participants, below the 242-participant average among 23 other Rosacea trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03841032, a NA study of Rosacea, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate if the test sunscreen skin care product will be well-tolerated and help facial redness when applied to the face after 4 weeks.
Conditions Studied
Interventions
- DRUG Coppertone, BAY1183345
Study Locations (1)
Virginia
- The Education & Research Foundation, Inc. - Lynchburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-01-28 |
| Est. Completion | 2019-02-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03841032
The ClinicalTrials.gov registry entry for NCT03841032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 242-participant average among 23 other Rosacea trials with a reported enrollment target (86% lower). The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rosacea appearing as the primary indexed condition, and to 1 intervention - of which Coppertone, BAY1183345 is the first listed.
NCT03841032 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT03841032 about?
NCT03841032 is a clinical study titled "4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness". The purpose of this study is to evaluate if the test sunscreen skin care product will be well-tolerated and help facial redness when applied to the face after 4 weeks.
What is the current status of trial NCT03841032?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2019-01-28. Estimated completion is 2019-02-25.
What conditions does trial NCT03841032 study?
This clinical trial studies the following conditions: Rosacea.
What interventions are being tested in trial NCT03841032?
The interventions under investigation include: Coppertone, BAY1183345 (DRUG).
Who is sponsoring clinical trial NCT03841032?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03841032 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rosacea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea
COMPLETED · NA
-
Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
RECRUITING · Phase 2
-
Analysis of the Microbiome in Rosacea
ACTIVE NOT RECRUITING · Early Phase 1
-
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.